Prokidney (PROK) Operating Leases (2021 - 2026)
Prokidney's (PROK) quarterly Operating Leases came in at $2.7 million in Q1 2026, up 6.49% year-on-year from $2.5 million in Q1 2025, and down 9.78% on a QoQ basis from $3.0 million in Q4 2025.
Prokidney (PROK) Operating Leases (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Operating Leases data on file, last reported at $2.7 million in Q1 2026.
- On a quarterly basis, Operating Leases rose 6.49% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 6.49% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 19.99% from the prior year.
- Operating Leases for Q1 2026 stood at $2.7 million, down from $3.0 million in the prior quarter.
- Over the last five years, Operating Leases for PROK reached as high as $5.6 million in Q2 2024 and fell as low as $1.7 million in Q3 2022.
- Historically, Operating Leases has averaged $3.2 million across 5 years, with a median of $2.7 million in 2026.
- Across the five-year window, Operating Leases soared 154.72% in 2024 and tumbled 48.3% in 2025, its largest moves.
- Year by year, Operating Leases stood at $1.9 million in 2022, then surged by 89.4% to $3.6 million in 2023, then tumbled by 31.55% to $2.5 million in 2024, then grew by 19.99% to $3.0 million in 2025, then dropped by 9.78% to $2.7 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $2.7 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.07 Mn |